Notably, PAQR8 CN gain in recurrent breast cancers was not restricted to patients who received anti-estrogen therapy as it was found with equal frequency among patients treated with other therapies, including chemotherapy and agents targeting Her2. The gene discussed is ERBB2; the disease is breast carcinoma.